NDC 54575-360
CANTALOUPE
Cantaloupe
CANTALOUPE is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Cantaloupe.
| Product ID | 54575-360_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-360 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CANTALOUPE |
| Generic Name | Cantaloupe |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | CANTALOUPE |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fruit Proteins [EXT] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 54575-360-10
10 mL in 1 VIAL, MULTI-DOSE (54575-360-10)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 54575-360-02 [54575036002]
CANTALOUPE INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-360-50 [54575036050]
CANTALOUPE INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-360-10 [54575036010]
CANTALOUPE INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-360-30 [54575036030]
CANTALOUPE INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CANTALOUPE | 1 g/20mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Allergens [CS]
- Dietary Proteins [CS]
- Fruit Proteins [EXT]
NDC Crossover Matching brand name "CANTALOUPE" or generic name "Cantaloupe"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-6115 | CANTALOUPE | Cantaloupe |
| 36987-1306 | Cantaloupe | Cantaloupe |
| 36987-1307 | Cantaloupe | Cantaloupe |
| 36987-1308 | Cantaloupe | Cantaloupe |
| 36987-1309 | Cantaloupe | Cantaloupe |
| 49288-0102 | Cantaloupe | Cantaloupe |
| 54575-360 | CANTALOUPE | cantaloupe |
Trademark Results [CANTALOUPE]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CANTALOUPE 90522851 not registered Live/Pending |
USA Technologies 2021-02-10 |
 CANTALOUPE 77454234 3540143 Dead/Cancelled |
Cantaloupe LLC 2008-04-22 |
 CANTALOUPE 75395038 2371481 Dead/Cancelled |
KARYS, INC. 1997-11-24 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.